ID   SK-MEL-27-1
AC   CVCL_U913
SY   SKMEL-27-1
DR   cancercelllines; CVCL_U913
DR   Cosmic; 1669142
DR   Wikidata; Q54954000
RX   PubMed=21725359;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6030 ! SK-MEL-27
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 12
//
RX   PubMed=21725359; DOI=10.1038/onc.2011.250; PMCID=PMC3267014;
RA   Xing, Feng
RA   Persaud, Yogindra
RA   Pratilas, Christine A.
RA   Taylor, Barry Stephen
RA   Janakiraman, Manickam
RA   She, Qing-Bai
RA   Gallardo, Humilidad F.
RA   Liu, C.
RA   Merghoub, Taha
RA   Hefter, Blake E.
RA   Dolgalev, Igor
RA   Viale, Agnes J.
RA   Heguy, Adriana
RA   de Stanchina, Elisa
RA   Cobrinik, David
RA   Bollag, Gideon
RA   Wolchok, Jedd D.
RA   Houghton, Alan N.
RA   Solit, David B.
RT   "Concurrent loss of the PTEN and RB1 tumor suppressors attenuates RAF
RT   dependence in melanomas harboring (V600E)BRAF.";
RL   Oncogene 31:446-457(2012).
//